Tirzepatide, single vial

Dual GIP/GLP-1 receptor agonist

Tirzepatide

Dual GIP/GLP-1 receptor agonist. Supplied for laboratory research use only.

  • Dual GIP/GLP-1 agonist; FDA-approved as Mounjaro, Zepbound
  • Also approved by EMA, MHRA, and TGA
  • This vial is unbranded -- not the approved injector
  • Supplied for laboratory research use only. Not for human or veterinary use.
$239.99$359.97 Save 33%
Choose your supply
Most Popular
Best Value
In stock, ready to ship

90-Day Money-Back Guarantee

Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.

Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.

What it is
CompoundTirzepatide, also designated LY3298176
ClassDual GIP/GLP-1 receptor agonist
FormLyophilised powder, supplied in a vial
OriginatorEli Lilly and Company
Development status

Tirzepatide is approved by the FDA as a prescription medicine. FDA approved as Mounjaro (type 2 diabetes, May 2022) and Zepbound (chronic weight management, Nov 2023; obstructive sleep apnea added Dec 2024). This product is not that medicine and is supplied for laboratory research use only.

Development status is stated above. No efficacy claim is made on this page.

Shipping & returns
ReturnsNinety days from delivery. Contact us and we will refund the purchase price.
Tirzepatide $239.99

The specifics

The details, if you want them.

DeveloperEli Lilly and Company
Development codeLY3298176
ClassDual GIP/GLP-1 receptor agonist
Amino acids39
Half-lifeapproximately 5 days
FormThis research vial is lyophilised powder; the approved pharmaceutical is a pre-filled injector
Receptor target(s)GIP receptor, GLP-1 receptor
Binding mechanismC20 fatty acid moiety covalently attached at lysine 20, enabling albumin binding

Development

Where it is up to.

Peer-reviewed and the basis for FDA/EMA/MHRA/TGA approval as Mounjaro/Zepbound. This vial is a separate, unapproved research product, not that approved medicine.

Questions

The questions people actually ask.

What is tirzepatide?
A synthetic peptide developed by Eli Lilly that acts on the GIP and GLP-1 receptors. This product is a research-only vial, not a prescription medicine.
Is this the same as Mounjaro or Zepbound?
No. Tirzepatide is FDA-approved as Mounjaro (type 2 diabetes) and Zepbound (weight management, sleep apnea) — both prescription, pre-filled injectors. This is a separate, unbranded research vial.
What does "Research Use Only" mean?
Research Use Only means exactly that: intended for laboratory and research settings only, not for human or animal use, consumption, diagnosis, treatment, cure, or prevention of any disease.
How is this vial supplied?
As a vial of lyophilised (freeze-dried) powder, sold for laboratory and research use only — a different physical product from the approved injector.
What is your refund policy?
Ninety days from delivery. If you decide against it inside that window, contact hello@getmrpeps.com and we will refund the purchase price. Damaged or incorrect orders are replaced or refunded regardless.